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Abstract
Background: Sex influences susceptibility to many infectious diseases, including some manifestations of
leishmaniasis. The disease is caused by parasites that enter to the skin and can spread to the lymph nodes, spleen,
liver, bone marrow, and sometimes lungs. Parasites induce host defenses including cell infiltration, leading to
protective or ineffective inflammation. These responses are often influenced by host genotype and sex. We
analyzed the role of sex in the impact of specific gene loci on eosinophil infiltration and its functional relevance.
Methods: We studied the genetic control of infiltration of eosinophils into the inguinal lymph nodes after 8 weeks of
Leishmania major infection using mouse strains BALB/c, STS, and recombinant congenic strains CcS-1,-3,-4,-5,-7,-9,-11,-12,
-15,-16,-18, and -20, each of which contains a different random set of 12.5% genes from the parental “donor” strain STS and
87.5% genes from the “background” strain BALB/c. Numbers of eosinophils were counted in hematoxylin-eosin-stained
sections of the inguinal lymph nodes under a light microscope. Parasite load was determined using PCR-ELISA.
Results: The lymph nodes of resistant STS and susceptible BALB/c mice contained very low and intermediate numbers of
eosinophils, respectively. Unexpectedly, eosinophil infiltration in strain CcS-9 exceeded that in BALB/c and STS and was
higher in males than in females. We searched for genes controlling high eosinophil infiltration in CcS-9 mice by linkage
analysis in F2 hybrids between BALB/c and CcS-9 and detected four loci controlling eosinophil numbers. Lmr14
(chromosome 2) and Lmr25 (chromosome 5) operate independently from other genes (main effects). Lmr14 functions only
in males, the effect of Lmr25 is sex independent. Lmr15 (chromosome 11) and Lmr26 (chromosome 9) operate in
cooperation (non-additive interaction) with each other. This interaction was significant in males only, but sex-marker
interaction was not significant. Eosinophil infiltration was positively correlated with parasite load in lymph nodes of F2
hybrids in males, but not in females.
Conclusions: We demonstrated a strong influence of sex on numbers of eosinophils in the lymph nodes after L. major
infection and present the first identification of sex-dependent autosomal loci controlling eosinophilic infiltration. The
positive correlation between eosinophil infiltration and parasite load in males suggests that this sex-dependent eosinophilic
infiltration reflects ineffective inflammation.
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Background
Sex influences susceptibility to many infectious diseases
[1], including some manifestations of leishmaniasis [2], a
disease that threatens several hundred million people in
98 countries [3]. Disability-adjusted life years (DALYs)
due to leishmaniasis are globally increasing [4]. The
disease is caused by intracellular protozoan parasites of the
genus Leishmania and is transmitted to the vertebrates by
the bite of female phlebotomine sand flies.
Leishmania parasites infect the so-called professional
phagocytes (neutrophils, monocytes, and macrophages),
as well as dendritic cells and fibroblasts. The major host
cell is the macrophage, where parasites multiply, eventu-
ally rupturing the cell and spread to the uninfected cells
(reviewed in [5]). Infected monocytes and macrophages
circulating in the peripheral blood are believed to be
carriers of the parasite to distal sites [6]. In the dermis,
parasites cause the cutaneous form of the disease (which
can be localized or diffuse), whereas infection of the mu-
cosa gives rise to mucocutaneous leishmaniasis. The meta-
static spread of the infection to the spleen and liver results
in visceral leishmaniasis. Although these are the major
sites of visceral disease, parasites can also enter other or-
gans, such as the bone marrow, lymph nodes, and lungs
(reviewed in [5]). Presence of parasites in organs usually
induces inflammation through cascade of signals that
leads to recruitment of inflammatory cells, such as neutro-
phils, macrophages, eosinophils, and dendritic cells. These
innate immune cells might phagocytose parasites and/or
produce cytokines and chemokines that activate both in-
nate and adaptive immune responses. Resulting responses
can be protective and eliminate parasites, or ineffective
and lead to chronic inflammation [7].
The sex of the host influences the incidence of disease,
parasite burden, pathology, mortality, and immunological
response against various parasites, including Leishmania
both in humans and in rodents (reviewed in [7–12]).
In general, sex bias is observed after infection with
Leishmania parasites, and men are more frequently in-
fected than women ([13–15]; reviewed in [11, 12]), al-
though in certain areas no sex bias in prevalence of
disease was observed [16]. The higher susceptibility of
males also applies to hamster [17] and mouse [18, 19];
reviewed in [12] models of leishmaniasis. The effect of
male orchidectomy and female testosterone replacement
studies suggests that the hormone testosterone can modu-
late systemic L. major infection in BALB/cAnPt, DBA/2N,
DBA/2J, and F1 hybrids (BALB/cAnPt x DBA/2N) mouse
strains [18].
Importantly, the host genes, including those regulated
differently in males and females, play a significant role in
determining susceptibility and organ tropism for infec-
tious diseases. Experimental data have shown different
sex influence on susceptibility to relatively closely related
pathogen species [20, 21], different sex biases in suscep-
tibility to the same Leishmania species in different host
genotypes [21, 22], and different sex and genetic influ-
ence on organ-specific pathology [21, 23, 24]. For ex-
ample, high resistance to skin lesions induced by L.
mexicana was observed in females but not in males of
DBA/2 mice, but the sex effect was opposite in L. major
infection [20].
Genotype influence on sex differences was defined in
the studies of L. major infection [22, 24]. Giannini [22]
found no sex effect on L. major-induced skin pathology
and mortality in BALB/cJ mice, but a higher susceptibility
of B10.129(10M)ScSn females than males. The compari-
son of L. major susceptibility in two strains, BALB/cHeA
and CcS-11 [24], has shown that there is no significant
sex influence on skin lesion development, splenomegaly,
and hepatomegaly in these strains. However, parasite
numbers in lymph nodes are higher in both BALB/c and
CcS-11 males; moreover, CcS-11 males have higher para-
site load in spleens, showing an organ-specific, sex-, and
genotype-dependent pathology [24].
In the present study, we address influence of genotype
and sex on infiltration of eosinophil leukocytes into the in-
guinal lymph nodes of L. major-infected mice. Eosinophils
are granulocytes that develop in the bone marrow from
pluripotent progenitors. They are released into the
peripheral blood in phenotypically mature state and can
be activated and recruited into tissues in response to ap-
propriate stimuli, most notable IL-5, and the eotaxin
chemokines [25].
Eosinophils contribute to the initiation of inflamma-
tory and adaptive responses due to their bidirectional in-
teractions with dendritic cells and T cells, as well as
their large spectrum of secreted cytokines and soluble
mediators. They have key immunoregulatory roles as
professional antigen-presenting cells and modulators of
functions of CD4+ T cells, dendritic cells, B cells, mast
cells, neutrophils, and basophils [26].
Eosinophil-associated disorders can affect practically
all tissues and organs in the body, either individually or
in combination. They are involved in inflammatory condi-
tions affecting the skin, cardiovascular, nervous and renal
system, gastrointestinal tract, and upper and lower airways
[27, 28], are key effector cells in eosinophilic asthma [29],
and their interaction with peripheral nerves has impact on
pathology of many diseases. In addition, they are also in-
volved in regulatory mechanisms modulating local and
systemic immune responses and remodeling and repair
mechanisms [30].
Eosinophils may have an important role in maintaining
host survival in life-threatening viral infections [31].
They combat worms such as Angiostrongylus cantonensis
[32], Nippostrongylus brasiliensis [33], Litomosoides
sigmodontis [34], and Brugia pahangi [35]; but their role
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in response to other nematoda is more complex. Eosinophils
have no role in protection against Schistosoma mansoni
[36]. They even promote larval growth in primary in-
fection with Trichinella spiralis [37], but they mediate
protective immunity against secondary infection with
this nematode [38].
Activated eosinophils can kill [39] or support killing of
L. major parasites [40]; however, in chronic disease, eo-
sinophil infiltration might be a consequence of an inef-
fective elimination of these parasites and/or an excessive
inflammatory response to the present pathogens [41].
Here, we analyzed genetic influence on eosinophil in-
filtration after L. major infection into the lymph nodes
of strains BALB/cHeA (BALB/c), STS/A (STS), and se-
lected 12 (out of 20) RC strains of CcS/Dem series [42].
Each of the 20 RC CcS/Dem strains contains a different
unique set of approximately 12.5% genes of the donor
strain STS on the genetic background of BALB/c. We
found surprisingly high numbers of eosinophils in the
inguinal lymph nodes of the strain CcS-9, males contain-
ing higher numbers of eosinophils than females. We an-
alyzed genetics of this infiltration using microsatellite
DNA markers and mapped four loci that control eosino-
phil numbers after L. major infection, one of them being
strongly influenced by sex. We also found that the num-
bers of eosinophils in the lymph nodes correlate posi-
tively with the parasite load and that this correlation is




Tests of strain differences in eosinophil infiltration: Mice of
the strains BALB/c (27 females, 27 males), STS (8 females, 9
males), CcS-1 (10 females, 13 males), CcS-3 (10 females, 10
males), CcS-4 (13 females, 12 males), CcS-5 (19 females, 27
males), CcS-7 (8 females, 12 males), CcS-9 (15 females, 10
males), CcS-11 (13 females, 13 males), CcS-12 (16 females,
12 males), CcS-15 (7 females, 12 males), CcS-16 (10 females,
13 males), CcS-18 (5 females, 3 males), and CcS-20 (13
females, 18 males) were infected with L. major as described
previously [43, 44]. Mice were tested in eight successive
experimental groups and were euthanized 8 weeks after in-
fection. The age of mice at the time of infection was 7 to
47 weeks (mean 15 weeks, median 14 weeks).
A linkage study of eosinophil infiltration: F2 hybrids
between CcS-9 and BALB/c (age 11 to 21 weeks at the
time of infection, mean and median age 14.8 and
15 weeks, respectively) were produced at the Institute of
Molecular Genetics. When used for these experiments,
the CcS-9 was in the 40th generation of inbreeding and
therefore highly homozygous. Two hundred fifty-four F2
hybrids between BALB/c and CcS-9 comprised 139
females and 115 males. Mice of the background parental
strains BALB/c (18 females, 17 males) and STS (8 fe-
males, 6 males) and the RC strain CcS-9 (16 females, 14
males), 7 to 20 weeks old at the time of infection (mean
13 weeks, median 13 weeks), were used as controls. During
the experiment, male and female mice were placed into sep-
arate rooms and males were caged individually. F2 mice
were tested in three independent experimental groups.
Ethical statement
All experimental procedures in this study comply with the
Czech Government Requirements under the Policy of
Animal Protection Law (No.246/1992) and with the regula-
tions of the Ministry of Agriculture of the Czech Republic
(No.207/2004), which are in agreement with all relevant
European Union guidelines for work with animals and were
approved by the Institutional Animal Care Committee of
the Institute of Molecular Genetics AS CR and by Depart-
mental Expert Committee for the Approval of Projects of
Experiments on Animals of the Academy of Sciences of the
Czech Republic (permissions Nr. 274/2011; 89/2013).
Parasites
L. major LV 561 (MHOM/IL/67/LRC-L137 JERICHO II)
was maintained in rump lesions of BALB/c females.
Amastigotes were transformed to promastigotes using
SNB-9 [43]. 107 promastigotes from the passage, two
cultivated for 6 days were inoculated in 50 μl sterile sa-
line s.c. into mouse rump [44].
Disease phenotype
The size of the primary skin lesion was measured weekly
using a Vernier caliper gauge. The mice were killed
8 weeks after infection and inguinal lymph nodes draining
the site of infection were collected for further analysis.
Histological analysis
Inguinal lymph nodes of female and male mice were fixed
in 10% neutral buffered formalin (NBF; approximately 4%
formaldehyde) and embedded in paraffin using automatic
tissue processor. Tissue sections (5–7 μm) were stained
with hematoxylin, differentiated into 1% acid alcohol,
stained with 1% alcoholic eosin, dehydrated, assembled
with permanent mounting medium, and analyzed under a
light microscope (Olympus BX51; Olympus Optical Co.
(EUROPA) GMBH., Hamburg, Germany).
Eosinophil infiltration in the experiment with parental
strains BALB/c, STS, and 12 RC strains was assessed using
a semi-quantitative scoring system: 0, no eosinophil; 0.25,
1 eosinophil; 0.5, 2 eosinophils; 0.75, 3–4 eosinophils; 1, 5
eosinophils; 1.5, 6 eosinophils; 2, 7 eosinophils; 2.5, 8–9
eosinophils; 3, 10–15 eosinophils; and 4, more than 15 eo-
sinophils per lymph node section (one section was used in
experiment with parental strains BALB/c, STS and 12 RC
strains).
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In F2 mice, as well as the parental strains BALB, STS,
and CcS-9, eosinophil numbers were determined quanti-
tatively. The total number of eosinophils was counted in
the node section and each lymph node was assessed in
four independent sections. The mean value of these four
counts was used to calculate the role of genetic factors in
control of eosinophil infiltration. Sixty slides from 15 mice
were blindly recounted by an independent investigator
with concordant results (R = 0.913, P value = 5.66 × 10−29).
Genotyping of F2 mice by PCR
DNA was isolated from tails using a standard proteinase
procedure. The strain CcS-9 differs from BALB/c at
STS-derived segments on eight chromosomes ([45] and
unpublished results). These differential segments were
typed in the F2 hybrid mice between CcS-9 and BALB/c
using 18 microsatellite markers (Research Genetics,
Huntsville, FL, USA): D2Mit283, D2Mit148, D4Mit172,
D4Mit23, D4Mit53, D4Mit17, D5Mit24, D5Mit143,
D6Mit122, D6Mit274, D9Mit15, D11Mit141, D11Mit242,
D11Nds18, D11Nds10, D16Mit19, D17Mit120, and
D17Mit122. The markers were selected because their gen-
omic location makes them suitable to detect linkage. The
maximum distance between any two markers in the
chromosomal segments derived from the strain STS or from
the nearest BALB/c derived markers was 12.46 cM, and
mean distance was 4.67 cM. The PCR genotyping for
markers with fragment length difference more than 8 bp
was performed using unlabeled primers as in [46, 47]. The
PCR genotyping for markers with fragment length difference
less than 8 bp was performed using [γ-32P]ATP end-labeled
primers as described elsewhere [48].
Measurement of parasite load in lymph nodes
Total DNA was isolated from the frozen lymph nodes, and
parasite load was measured using PCR-ELISA according to
the previously published protocol [49]. Briefly, for detection
of Leishmania parasite DNA, in total DNA, PCR was per-
formed using two primers (digoxigenin-labeled F 5′-ATT
TTA CAC CAA CCC CCA GTT-3′ and biotin-labeled R
5′-GTG GGG GAG GGG CGT TCT-3′ (VBC Genomics
Biosciences Research, Austria). The 120-bp fragment within
the conserved region of the kinetoplast minicircle of
Leishmania parasite was amplified. In each PCR reaction,
50 ng of extracted total DNA was used. As a positive con-
trol, 20 ng of L. major DNA per reaction was amplified as a
highest concentration of the standard. A 26-cycle PCR reac-
tion was used for quantification of parasites. Parasite load
was determined by measurement of the PCR product with
the modified ELISA protocol (Pharmingen, San Diego,
USA). The concentration of Leishmania DNA was mea-
sured at the ELISA Reader Tecan with the curve fitter pro-
gram KIM-E (Schoeller Pharma, Prague, Czech Republic)
using least squares-based linear regression analysis [24, 49].
Statistical analysis
The differences among BALB/c, STS, and CcS/Dem
strains in eosinophil numbers in lymph nodes were evalu-
ated by the analysis of variance (ANOVA) and Newman-
Keuls multiple comparison test at 95% significance using
the program Statistica for Windows 12.0 (StatSoft, Inc.,
Tulsa, OK, USA).
Differences between sexes in BALB/c, STS, and CcS/
Dem strains were calculated by ANOVA (Statistica for
Windows 12.0; StatSoft, Inc., Tulsa, OK, USA).
The role of genetic factors in control of eosinophil infil-
tration in F2 hybrids was examined by ANOVA (Statistica
for Windows 12.0; StatSoft, Inc., Tulsa, OK, USA). In
order to obtain normal distribution of the analyzed par-
ameter required for ANOVA, the obtained values were
transformed as shown in the legends of tables. Markers
and interactions with P < 0.05 were combined in a single
comparison. In all ANOVA analyses strain or genotype,
sex, and age were fixed factors, and the experiment was
considered a random parameter.
For each independent variable, the partial R2 was com-
puted in the usual way by subtracting the regression
sums of squares of the model without the variable
(SS(b1,b2,b3,b4|b0)) of interest from the regression sums
of squares of the full model (SS(b1,b2,b3,b4,b5|b0)); this
difference divided by total regression sums of squares
((SS(b1,b2,b3,b4,b5|b0)):
SS b1; b2; b3; b4jb0ð Þð Þ − SS b1; b2; b3; b4; b5jb0ð Þð Þ
SS b1; b2; b3; b4; b5jb0ð Þð
indicated the contribution of the independent variable.
To obtain whole-genome significance values (corrected
P values) the observed P values (aT) were adjusted
according to Lander and Schork [50] using the formula:
αT≈ C þ 2ρGh Tð Þ½ αT
where G = 1.75 Morgan (the length of the segregating
part of the genome: 12.5% of 14 M); C = 8 (number of
chromosomes segregating in cross between CcS-9 and
BALB/c); ρ = 1.5 for F2 hybrids; h(T) = the observed sta-
tistics (F ratio).
The Spearman correlation coefficients between para-
site numbers and eosinophil infiltration in the lymph
nodes of F2 hybrid mice were computed using the pro-
gram Statistica for Windows 12.0 (StatSoft, Inc., Tulsa,
OK, USA).
Results
Infiltration of eosinophils into the inguinal lymph nodes
in parental strains BALB/c and STS and selected RC strains
We infected with L. major both females and males of
the strains BALB/c, STS, and RC strains CcS-1, CcS-3,
CcS-4, CcS-5, CcS-7, CcS-9, CcS-11, CcS-12, CcS-15,
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CcS-16, CcS-18, and CcS-20 and used semi-quantitative
scoring system to assess eosinophil infiltration (Table 1).
These studies showed mild and no infiltration into the
lymph nodes of parental strains BALB/c (Fig. 1a, b) and
STS (Fig. 1c, d), respectively. Strains CcS-9 (P = 0.00020)
(Fig. 1e, f ) and CcS-12 (P = 0.0024) exhibit significantly
higher eosinophil infiltration in their lymph nodes than
the background parental strain BALB/c. BALB/c and
CcS-9 males presented higher eosinophil infiltration
than females of these strains P = 0.0089 and P = 0.016,
respectively. 80% of examined CcS-9 males in compari-
son with 26.67% of CcS-9 females contained infiltrating
eosinophils, 50% of males having 7 and more eosinophils
in their lymph nodes (Table 1). Sex difference in strains
CcS-7,-11, and -18 was not significant. Strain CcS-9 with
the highest eosinophil infiltration (Table 1) was selected
for further genetic studies.
Four novel loci control eosinophil infiltration in leishmaniasis
We examined eosinophil numbers in lymph nodes in 254
F2 hybrids between the strains BALB/c and CcS-9. The
strain CcS-9 differs from BALB/c at STS-derived genetic
regions located at eight chromosomes ([45], Šíma unpub-
lished data). These differential STS-derived segments were
genotyped in the F2 hybrid mice using 18 microsatellite
markers. A statistical analysis of linkage revealed four gen-
etic loci that influence eosinophil infiltration into the in-
guinal lymph nodes after L. major infection.
Table 1 Eosinophil numbers in inguinal lymph nodes of L. major-infected mice
% of mice with number of eosinophils (graded as 0–4) in section of inguinal lymph node
0 0.25 0.5 0.75 1 1.5 2 2.5 3 4
Strain Sex 0 1 2 3–4 5 6 7 8–9 10–15 >15
BALB/c Females 100.00 0 0 0 0 0 0 0 0 0
Males 81.48 0 3.70 0 3.70 3.70 7.41 0 0 0
STS Females 100.00 0 0 0 0 0 0 0 0 0
Males 100.00 0 0 0 0 0 0 0 0 0
CcS-1 Females 80.00 0 0 0 10.00 0 10.00 0 0 0
Males 76.92 7.69 0 0 15.38 0 0 0 0 0
CcS-3 Females 100.00 0 0 0 0 0 0 0 0 0
Males 90.00 0 0 0 10.00 0 0 0 0 0
CcS-4 Females 92.31 0 7.69 0 0 0 0 0 0 0
Males 91.67 0 0 0 0 0 0 0 8.33 0
CcS-5 Females 100.00 0 0 0 0 0 0 0 0 0
Males 96.30 0 0 0 3.70 0 0 0 0 0
CcS-7 Females 100.00 0 0 0 0 0 0 0 0 0
Males 75.00 0 0 0 25.00 0 0 0 0 0
CcS-9 Females 73.33 0 0 0 20.00 0 6.67 0 0 0
Males 20.00 0 10.00 0 20.00 0 10.00 20.00 20.00 0
CcS-11 Females 84.62 0 7.69 7.69 0 0 0 0 0 0
Males 61.54 0 23.08 0 7.69 0 7.69 0 0 0
CcS-12 Females 56.25 0 0 0 31.25 6.25 0 0 6.25 0
Males 50.00 0 8.33 0 16.67 0 16.67 0 0 8.33
CcS-15 Females 100.00 0 0 0 0 0 0 0 0 0
Males 91.67 0 8.33 0 0 0 0 0 0 0
CcS-16 Females 90.00 0 10.00 0 0 0 0 0 0 0
Males 100.00 0 0 0 0 0 0 0 0 0
CcS-18 Females 100.00 0 0 0 0 0 0 0 0 0
Males 33.33 0 66.67 0 0 0 0 0 0 0
CcS-20 Females 92.31 0 0 0 7.69 0 0 0 0 0
Males 95.00 0 0 0 5.00 0 0 0 0 0
Eosinophil numbers in lymph nodes depending on genotype and sex. Eosinophil infiltration was evaluated as described in the “Methods” section.
Numbers higher than 75% are shown in italics
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The effects of Lmr14 (L. major response 14) linked to
D2Mit283 (corrected P value = 0.0081) and Lmr25 linked
to D5Mit143 (corrected P value = 0.044) were detectable
and significantly independent of each other or other
genes (the main effects) (Table 2). Lmr14 operated only
in males (corr. P value of marker and sex interaction
=0.0085)(Table 2, Fig. 2), higher numbers of eosinophils
were associated with presence of BALB/c (C) allele
(Fig. 2c). The P value for Lmr14 was significant only in
cross (CcS-9 × BALB/c)F2 (where the mother of the F1
hybrids was CcS-9 and the father was BALB/c) (Fig. 2c),
but not in cross (BALB/c × CcS-9)F2 (where the mother
was BALB/c and the father was CcS-9) (Fig. 2d). How-
ever, interaction between the cross and marker
D2Mit283 was not significant (corr. P = 0.6). The effect
of Lmr25 was not influenced by sex, and higher numbers
of eosinophils were observed in heterozygotes (Table 2).
In contrast to the main effects of Lmr14 and Lmr25,
Lmr15 (linked to D11Nds10) and Lmr26 (linked to
D9Mit15) operated in cooperation with each other (non-
additive, epistatic, interaction) (corrected P = 0.010). F2
male mice of the cross (BALB/c × CcS-9)F2 with homo-
zygous BALB/c (CC) alleles at both Lmr26 and Lmr15
had nearly nine times higher numbers of eosinophils in
the lymph nodes than mice with homozygous STS (SS)
alleles at both these loci, and nearly 90 times higher than
mice with homozygous CC alleles at Lmr26 and CS al-
leles at Lmr15 (Table 3). The linkage was detected only
in males, but the interaction between sex and marker
was not significant (corr. P = 0.19).
Positive correlation between parasite numbers and
eosinophils in the inguinal lymph nodes
We have determined parasite load in the lymph nodes of
the F2 hybrids between BALB/c and CcS-9 and analyzed
the relationship between parasite numbers in lymph
nodes and eosinophil infiltration to this organ. In both
sexes pooled, there was a positive correlation between
parasite numbers and eosinophil infiltration R = 0.39,
P = 1.3 × 10−10, and the correlation was significant in
males R = 0.29, P = 0.0017, but not in females R = 0.14,
P = 0.10. This correlation is at least partly controlled by
Lmr loci, because in F2 hybrid mice, this correlation was
positive in male homozygous for the Lmr14 (D2Mit283)
BALB/c allele (CC) (R = 0.51, P = 0.016) and STS allele
(SS) (R = 0.50, P = 0.00088), but no correlation was ob-
served in heterozygotes (R = −0.013, P = 0.92).
Discussion
Eosinophil infiltration in strain CcS-9 exceeds that of both
parents
Strain CcS-9 that contains a set of approximately 12.5%
genes of the donor strain STS and 87.5% genes of the
background strain BALB/c exhibited numbers of infil-
trating eosinophils (Fig. 1, Table 1) exceeding those in
both parental strains BALB/c and STS. The observations
of progeny having a phenotype, which is beyond the
range of the phenotype of its parents, are not rare in
traits controlled by multiple genes. It was detected in
different tests of immune responses of RC strains in
vitro [51–56] and in vivo [21, 57–60], and in analysis of
Fig. 1 Eosinophils in hematoxylin-eosin-stained inguinal lymph node sections of L. major-infected female and male mice. a BALB/c female, b BALB/c
male, c STS female, d STS male, e CcS-9 female, and f CcS-9 male with detail of eosinophils. Arrows show positions of eosinophils
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Table 2 Main effect of loci that control eosinophil numbers in the inguinal lymph nodes of L. major-infected F2 hybrids between
CcS-9 and BALB/c





Lmr14 Both sexes D2Mit283 2.62 1.229 ±0.003 3.62 1.234 ±0.002 2.67 1.229 ±0.002 NS NS NA
(n = 57) (n = 111) (n = 74)
Females 1.24 1.217 ±0.003 1.45 1.220 ±0.002 1.62 1.221 ±0.003 NS NS NA
(n = 35) (n = 61) (n = 32)
Males both crosses 5.15 1.239 ±0.005 8.94 1.247 ±0.003 4.02 1.236 ±0.004 5.5 × 10−2 NS NA
(n = 22) (n = 50) (n = 41)
Males (BALB/c × CcS-9)F2 3.37 1.233 ±0.006 9.09 1.242 ±0.004 3.78 1.235 ±0.005 NS NS NA
(n = 15) (n = 32) (n = 27)
Males (CcS-9 × BALB/c)F2 13.63 1.253 ±0.005 18.34 1.257 ±0.004 4.51 1.237 ±0.005 1.08 × 10
−4 8.11 × 10−3 36.22
(n = 7) (n = 18) (n = 14)
Lmr25 Both sexes D5Mit143 2.07 1.225 ±0.003 4.33 1.237 ±0.002 1.96 1.225 ±0.003 9.53 × 10−4 4.36 × 10−2 5.02
(n = 66) (n = 107) (n = 67)
Females 1.09 1.215 ±0.003 2.04 1.225 ±0.002 1.20 1.216 ±0.003 6.3 × 10−3 NS NA
(n = 37) (n = 56) (n = 36)
Males 5.71 1.241 ±0.004 7.40 1.244 ±0.003 4.41 1.237 ±0.004 NS NS NA
(n = 31) (n = 51) (n = 31)
Mean and SE values were obtained by analysis of variance. In order to obtain normal distribution required for analysis of variance, the value of eosinophil
numbers in the inguinal lymph nodes was transformed by using the 0.1th power of natural logarithm of the (observed value ×1000). The numbers in bold give
the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively
n number of mice
Fig. 2 Effects of genotype and sex on eosinophil infiltration at Lmr14 (D2Mit283) a females (corr. P = NS), b males (corr. P = NS), c males (CcS-9 ×
BALB/c)F2 cross (corr. P = 8.11 × 10
−3), and d males (BALB/c × CcS-9)F2 cross (corr. P = NS).These data are shown for sex and genotype CC—BALB/
c homozygotes, CS—heterozygotes, SS—STS homozygotes as mean ± SD. NS not significant
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expression quantitative trait loci (QTLs) from the livers of
chromosome substitution strains [61]. These observations
are due to multiple gene-gene interactions of QTLs, which
in new combinations of these genes in RC or chromosomal
substitution strains can lead to the appearance of new phe-
notypes that exceed their range in parental strains. In
addition, with traits controlled by multiple loci, parental
strains often contain eosinophil high infiltration alleles at
Table 3 Interaction between loci controlling eosinophil numbers in the inguinal lymph nodes in L. major-infected F2 hybrids
between CcS-9 and BALB/c
D9Mit15 (Lmr26)
CC CS SS
P = 3.7 × 10−2 Corr. P = NS % of expl. var. = NA
D11Nds10 (Lmr15) CC 4.24 1.236 ±0.006 3.03 1.231 ±0.004 2.19 1.226 ±0.005
Both sexes (n = 13) (n = 26) (n = 17)
CS 1.45 1.220 ±0.004 3.76 1.235 ±0.003 3.88 1.235 ±0.003
(n = 21) (n = 63) (n = 39)
SS 2.56 1.229 ±0.005 2.37 1.228 ±0.004 3.36 1.233 ±0.005
(n = 17) (n = 30) (n = 16)
P = 0.67 Corr. P = NS % of expl. var. = NA
D11Nds10 (Lmr15) CC 1.89 1.224 ±0.007 1.60 1.221 ±0.004 1.42 1.219 ±0.005
Females (n = 6) (n = 18) (n = 10)
Both crosses CS 1.37 1.219 ±0.005 1.53 1.220 ±0.003 2.28 1.227 ±0.005
(n = 11) (n = 38) (n = 17)
SS 1.67 1.222 ±0.007 1.46 1.220 ±0.004 1.06 1.214 ±0.007
(n = 7) (n = 16) (n = 6)
P = 2.63 × 10−4 Corr. P = 1.037 × 10−2 % of expl. var. = 15.35
D11Nds10 (Lmr15) CC 11.71 1.251 ±0.010 12.05 1.251 ±0.008 3.49 1.234 ±0.008
Males (n = 7) (n = 8) (n = 7)
Both crosses CS 1.06 1.214 ±0.007 23.15 1.260 ±0.005 12.22 1.251 ±0.004
(n = 10) (n = 25) (n = 22)
SS 6.55 1.243 ±0.008 5.18 1.239 ±0.005 7.27 1.244 ±0.007
(n = 10) (n = 14) (n = 10)
P = 0.41 Corr. P = NS % of expl. var. = NA
D11Nds10 (Lmr15) CC 10.37 1.249 ±0.008 12.60 1.252 ±0.006 6.78 1.243 ±0.008
Males (n = 2) (n = 2) (n = 3)
Cross CcS-9 × BALB CS 8.49 1.246 ±0.022 21.20 1.258 ±0.004 9.85 1.248 ±0.007
(n = 2) (n = 10) (n = 10)
SS 6.92 1.244 ±0.012 3.75 1.235 ±0.007 13.88 1.253 ±0.022
(n = 4) (n = 4) (n = 2)
P = 3.97 × 10−4 Corr. P = 1.629 × 10-2 % of expl. var. = 21.19
D11Nds10 (Lmr15) CC 44.01 1.267 ±0.012 32.78 1.264 ±0.010 8.88 1.247 ±0.016
Males (n = 5) (n = 6) (n = 4)
Cross BALB × CcS-9 CS 0.47 1.199 ±0.010 13.04 1.252 ±0.006 12.40 1.252 ±0.006
(n = 8) (n = 15) (n = 12)
SS 9.73 1.248 ±0.011 6.78 1.243 ±0.007 4.84 1.238 ±0.008
(n = 6) (n = 10) (n = 8)
Mean and SE values were obtained by analysis of variance. In order to obtain normal distribution required for analysis of variance value of eosinophil numbers in
serum inguinal lymph nodes was transformed by using the 0.1th power of natural logarithm of the (observed value ×1000). The numbers in bold give the average
non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively
n number of mice
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some of them and eosinophil low infiltration alleles at
others, and some progeny may receive predominantly eo-
sinophil high infiltration alleles from both parents.
Sex influence on eosinophil infiltration
Our data show a sex influence on eosinophil numbers in the
inguinal lymph nodes. Differences between the immune
system of females and males have been well documented
[62–64] and could result in differences in susceptibility to
diseases with immune component. Immune responses in-
cluding those involving eosinophils might be modulated by
steroid hormones [65, 66]. Moreover, some of the differ-
ences between females and males might be due to sex-
specific genetic architecture, characterized by profound
gene-sex interactions [67, 68]. This would mean that some
genes controlling response to L. major might operate differ-
ently in the two sexes. Indeed, locus Lmr14 controls eosino-
phil infiltration only in males. Genes controlling infections
that appear to be sex dependent have been observed also
with other infectious agents such as viruses [69–71], bacteria
[72], parasites [58], and fungi [73] and helminths [74]. Some
of sex-dependent QTLs exhibit a higher or exclusive influ-
ence on susceptibility in females [58, 69, 71–73] or males
[69, 71–74], phenotypic effect of other genes is present in
both sexes, but with opposite direction of effect [69, 70]. All
these reported loci are situated on autosomal chromosomes.
In contrast to the sex chromosomes, the autosomal genome
is shared by both sexes. However, although the DNA se-
quence, gene structure, and frequency of polymorphism on
the autosomes do not differ between males and females, the
regulatory genome is sexually dimorphic [68].
Future genetic and functional studies will help to es-
tablish the mechanistic basis of the observed gene-sex
interactions.
Loci controlling eosinophil infiltration and other immune
traits
The Lmr loci influencing eosinophil infiltration may be
related to QTLs that determine certain immunologically
relevant traits, because they co-map with other immuno-
logical functional polymorphisms.
Interestingly, two of the eosinophil controlling loci,
Lmr15 and Lmr26 co-localize with loci that determine
hemopoietic cell cycling measured by cobblestone area-
forming cell (CAFC) assay using cells from the bone
marrow [75]. Lmr15 encompasses the mouse ortholog of
human gene IL5, whose polymorphism was found to be
associated with eosinophil counts in the blood [76], and
Lmr26 co-localizes also with locus Tria5 that modifies in
vitro proliferation of mouse splenocytes stimulated by
soluble anti-CD3 [77].
The four described loci comprise several genes (Fig. 3),
whose biological function is compatible with the effects on
eosinophil infiltration [78–90] and their potential role can
now be investigated. However, the effects of these Lmr loci
might be also caused by genes that are at the present not
considered as candidates. The issue of identity of eosinophil
controlling genes and their possible relationship to other im-
mune traits will be resolved by a recombinational analysis.
The positive correlation between eosinophil infiltration
and parasite load suggests that the observed eosinophilic
infiltration reflects ineffective inflammation. This is in
Fig. 3 Loci controlling eosinophil numbers in CcS-9. The regions of STS and BALB/c origins are represented as dark and white, respectively; the boundary
regions of undetermined origin are shaded. C and S indicate the presence of BALB/c and STS allele, respectively. Only the markers and SNPs defining the
boundaries the STS-derived segment and the markers that were tested for linkage are shown. The markers that exhibit significant P values (genome-wide
corrected) are shown in bold. Lmr loci on chromosomes 2 and 11 detected in a cross between CcS-9 and BALB/c overlap with loci Lmr14 [91–93] and
Lmr15 [91, 93] detected in cross of CcS-16 with BALB/c, and were therefore given the same name. Abbreviations show genes that have been reported
to be involved in eosinophil functions: Bcl2l1 (BCL2-like 1) [78], Ccl11 (chemokine (C-C motif) ligand 11) [79] Ccl3 (chemokine (C-C motif) ligand 3) [79],
Ccl5 (chemokine (C-C motif) ligand 5) [79], Ccl7 (chemokine (C-C motif) ligand 7) [79], Ccl8 (chemokine (C-C motif) ligand 8) [80], Ccrl2 (chemokine
(C-C motif) receptor-like 2) [81], Cish (cytokine inducible SH2-containing protein) [82], Gnai2 (guanine nucleotide binding protein (G protein), alpha
inhibiting 2) [83], Hck (hemopoietic cell kinase) [84], Hmgb1 (high mobility group box 1) [85], Il13 (interleukin 13) [86], Il3 (interleukin 3) [87], Il4 (interleukin 4)
[88], Il5 (interleukin 5) [89], and Nlrp3 (NLR family, pyrin domain containing 3) [90]. However, the effects of eosinophil controlling loci might be caused by
genes that are at the present not considered as candidates
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agreement with kinetic studies showing that parasite
presence preceded presence of infiltrating cells including
eosinophils. This infiltration was higher in mice that
were unable to control infection [41].
We have found positive correlation between eosinophil
infiltration and parasite numbers in Lmr14 in homozy-
gous (CC or SS), but not in heterozygous (CS) F2 hybrid
males. The lack of positive correlation between eosino-
phil infiltration and parasite load in Lmr14 heterozygotes
(CS) may reflect a more effective inflammation process,
perhaps facilitated by other phenotypic effects of Lmr14
that include circulating levels of IFNγ, TNF, IgE, and IL-
12 [91] and possibly other as yet undetected regulatory
effects. This possibility has to be tested in future
experiments.
Conclusions
This is the first demonstration of genetic loci and sex in-
fluence controlling infiltration of eosinophils into the
lymph nodes and its relationship with parasite load.
Some of these loci comprise genes with broader bio-
logical and immunological effects, so they might be rele-
vant also in control of other diseases and symptoms
mediated by eosinophils.
Our data also suggest that ignoring sex in gene map-
ping might prevent detection of sex-dependent QTLs.
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